Offshore - Abbott Laboratories (ABT, $128.45)
Sector: Healthcare: Medical Devices
Recently raised annual outlook while reporting earnings above analyst estimates.
Abbott raised its outlook for 2021 adjusted earnings from continuing operations to between $5.00 and $5.10 per share, compared with its previous forecast of $4.30 to $4.50 per share.
On an adjusted basis, the company earned $1.40 per share, beating estimates of 95 cents per share, according to Refinitiv IBES data.
Technical Setup: Consolidating below year-to-date highs while developing a pennant. I like it +$130, with a stop of $123.40.
Sector: Healthcare: Medical Devices
Recently raised annual outlook while reporting earnings above analyst estimates.
Abbott raised its outlook for 2021 adjusted earnings from continuing operations to between $5.00 and $5.10 per share, compared with its previous forecast of $4.30 to $4.50 per share.
On an adjusted basis, the company earned $1.40 per share, beating estimates of 95 cents per share, according to Refinitiv IBES data.
Technical Setup: Consolidating below year-to-date highs while developing a pennant. I like it +$130, with a stop of $123.40.